KPV Pathways KPV (Lys-Pro-Val) acts as the C-terminal tripeptide of -melanocyte-stimulating hormone and retains many of -MSH's anti-inflammatory properties without significant melanocortin receptor activity
Such an imbalance is a primary driver for mood disorders such as anxiety, insomnia, paranoia, irritability, depression and psychosis, as well as common conditions such as ADHD, Panic Disorders and Post Partum Depression
It is not manufactured or labeled for human cosmetic use, clinical application, or any consumer-facing formulation, and it must not be applied, injected, or otherwise administered to humans.
Together these results suggested that the balancing of oxidative cellular status involves the increase in active GSH efflux to extracellular medium [36]